HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Edward T Ryan Selected Research

Cholera

8/2015Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh.
7/2015A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
3/2015Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera.
1/2015Gut microbial succession follows acute secretory diarrhea in humans.
8/2014Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses.
5/2014Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.
2/2014Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.
10/2013Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.
6/2013Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
1/2013Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Edward T Ryan Research Topics

Disease

36Infection
10/2015 - 07/2003
35Cholera
08/2015 - 08/2003
11Typhoid Fever (Typhoid)
09/2015 - 09/2006
7Diarrhea
02/2012 - 10/2004
4Malaria
03/2014 - 09/2006
3Bacteremia
09/2015 - 09/2006
2Fever (Fevers)
09/2015 - 03/2014
2Convalescence
08/2015 - 04/2015
2Inflammation
03/2015 - 09/2009
2Cryptosporidiosis
02/2012 - 07/2011
1Sepsis (Septicemia)
09/2015
1Malnutrition
09/2015
1Pneumonia (Pneumonitis)
09/2015
1Salmonella Infections (Salmonellosis)
06/2015
1Headache (Headaches)
04/2015
1Paratyphoid Fever
03/2014
1Rabies (Hydrophobia)
02/2014
1Dehydration (Water Stress)
04/2012
1Hepatitis A (Hepatitis, Infectious)
02/2012
1Communicable Diseases (Infectious Diseases)
12/2011
1Reactive Arthritis (Reiter Disease)
09/2009
1Arthritis (Polyarthritis)
09/2009
1Bacillary Dysentery (Shigellosis)
09/2009
1Hemolytic-Uremic Syndrome
02/2006
1Amebiasis (Amoebiasis)
02/2004
1Schistosomiasis (Bilharziasis)
02/2004
1Strongyloidiasis
02/2004

Drug/Important Bio-Agent (IBA)

35AntigensIBA
08/2015 - 07/2003
17Immunoglobulin A (IgA)IBA
04/2015 - 08/2003
16Cholera ToxinIBA
10/2013 - 08/2003
14Immunoglobulin G (IgG)IBA
05/2014 - 10/2004
13AntibodiesIBA
04/2014 - 08/2003
8VaccinesIBA
10/2013 - 08/2005
7Proteins (Proteins, Gene)IBA
03/2015 - 07/2003
5O Antigens (O Antigen)IBA
07/2015 - 11/2012
4Carbon MonoxideIBA
10/2015 - 01/2008
4Anti-Bacterial Agents (Antibiotics)IBA
09/2015 - 11/2009
4Immunoglobulin M (IgM)IBA
05/2014 - 10/2004
4Cholera VaccinesIBA
10/2013 - 08/2006
3Biological Markers (Surrogate Marker)IBA
09/2009 - 01/2008
2OxygenIBA
01/2015 - 04/2012
2Bacterial Proteins (Bacterial Protein)IBA
05/2013 - 09/2006
2N 30IBA
01/2013 - 05/2011
2Vitamin A (Retinol)FDA LinkGeneric
11/2008 - 01/2008
1LeptinIBA
08/2015
1Tetanus ToxinIBA
07/2015
1squaric acidIBA
07/2015
1InflammasomesIBA
03/2015
1Mitogen-Activated Protein KinasesIBA
03/2015
1Toll-Like Receptor 4IBA
03/2015
1Interleukin-9 (Interleukin 9)IBA
06/2014
1Interleukin-17 (Interleukin 27)IBA
06/2014
1CytokinesIBA
06/2014
1Interleukin-13IBA
06/2014
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
02/2014
1Rabies Vaccines (Rabies Vaccine)FDA Link
02/2014
14-O-carboxymethylascochlorinIBA
11/2012
11-oleoyl-2-stearoylphosphatidylcholineIBA
11/2012
1Bovine Serum AlbuminIBA
11/2012
1atovaquone-proguanilIBA
02/2012
1Pyridinolcarbamate (P23)IBA
02/2012
1Blood Group Antigens (Blood Groups)IBA
12/2011
1Conjugate VaccinesIBA
10/2011
1InterferonsIBA
06/2011
1Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link
08/2010
1lipopolysaccharide AIBA
11/2009
1Shigella VaccinesIBA
09/2009
1Histocompatibility Antigens (Histocompatibility Antigen)IBA
09/2009
1Complement System Proteins (Complement)IBA
08/2009
1MicronutrientsIBA
11/2008
1ZincIBA
11/2008
1Immunoglobulins (Immunoglobulin)IBA
10/2008
1Bacterial AntigensIBA
01/2008
1Fimbriae Proteins (Pilin)IBA
10/2006
1PrimaquineFDA Link
09/2006
1CVD 112IBA
08/2006
1Peru 15IBA
08/2006
1cholera vaccine CVD 103-HgRIBA
08/2006
1Shiga Toxin (Shigella Toxin)IBA
02/2006
1Intestinal helminthiasisIBA
02/2004
1Mannose (D-Mannose)IBA
08/2003
1Hemagglutinins (Hemagglutinin)IBA
08/2003
1SecretinFDA Link
07/2003

Therapy/Procedure

5Chemoprevention
03/2014 - 09/2006
1Organ Transplantation
01/2005